Nantkwest Inc (NK) Stake Boosted by Millennium Management LLC

Share on StockTwits

Millennium Management LLC lifted its stake in Nantkwest Inc (NASDAQ:NK) by 27.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 200,430 shares of the biotechnology company’s stock after purchasing an additional 43,686 shares during the quarter. Millennium Management LLC’s holdings in Nantkwest were worth $613,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of Nantkwest by 40.9% in the 1st quarter. JPMorgan Chase & Co. now owns 46,068 shares of the biotechnology company’s stock worth $179,000 after purchasing an additional 13,366 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Nantkwest by 40.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 170,271 shares of the biotechnology company’s stock worth $521,000 after purchasing an additional 49,040 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Nantkwest by 144.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 216,272 shares of the biotechnology company’s stock worth $662,000 after purchasing an additional 127,694 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Nantkwest by 72.2% in the 2nd quarter. Renaissance Technologies LLC now owns 520,400 shares of the biotechnology company’s stock worth $1,592,000 after purchasing an additional 218,200 shares during the last quarter. 13.55% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts recently commented on NK shares. ValuEngine upgraded Nantkwest from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. Citigroup downgraded Nantkwest to a “hold” rating and set a $3.00 price objective for the company. in a report on Friday, August 10th. Zacks Investment Research upgraded Nantkwest from a “hold” rating to a “buy” rating and set a $4.25 price objective for the company in a report on Wednesday, October 10th. Finally, BidaskClub upgraded Nantkwest from a “sell” rating to a “hold” rating in a report on Friday, September 28th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. Nantkwest currently has an average rating of “Hold” and a consensus price target of $3.63.

In other Nantkwest news, Director Steve Gorlin sold 50,000 shares of the business’s stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $3.07, for a total transaction of $153,500.00. Following the completion of the sale, the director now directly owns 224,805 shares in the company, valued at approximately $690,151.35. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 72.30% of the stock is currently owned by company insiders.

NASDAQ NK opened at $2.75 on Friday. Nantkwest Inc has a one year low of $2.16 and a one year high of $5.47. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.45 and a current ratio of 5.45.

ILLEGAL ACTIVITY NOTICE: “Nantkwest Inc (NK) Stake Boosted by Millennium Management LLC” was posted by Week Herald and is owned by of Week Herald. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://weekherald.com/2018/11/10/nantkwest-inc-nk-stake-boosted-by-millennium-management-llc.html.

Nantkwest Company Profile

NantKwest, Inc engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.S.

Further Reading: Stock Symbols Definition, Examples, Lookup

Want to see what other hedge funds are holding NK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nantkwest Inc (NASDAQ:NK).

Institutional Ownership by Quarter for Nantkwest (NASDAQ:NK)

Receive News & Ratings for Nantkwest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nantkwest and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply